56 related articles for article (PubMed ID: 8731355)
1. An in vitro model to study the effect of antibodies and cell receptor analogues on meningococcal adherence to human oroepithelial cells.
Carbonare SB; Nuñez-Vaca SP; Bajerl P; Honorio AC; Silva ML; Carneiro-Sampaio MM
Braz J Med Biol Res; 1996 Feb; 29(2):239-44. PubMed ID: 8731355
[TBL] [Abstract][Full Text] [Related]
2. The antimeningococcal vaccine VAMENGOC B-C induced poor serum and salivary antibody response in young Brazilian children.
Carbonare SB; Arslanian C; Silva ML; Farhat CK; Carneiro-Sampaio MM
Pediatr Infect Dis J; 1995 Sep; 14(9):797-803. PubMed ID: 8559631
[TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial.
Lieberman JM; Chiu SS; Wong VK; Partidge S; Chang SJ; Chiu CY; Gheesling LL; Carlone GM; Ward JI
JAMA; 1996 May; 275(19):1499-503. PubMed ID: 8622225
[TBL] [Abstract][Full Text] [Related]
4. An ELISA study of the antibody response after vaccination with a combined meningococcal group B polysaccharide and serotype 2 outer membrane protein vaccine.
Rosenqvist E; Tjade T; Frøholm LO; Frasch CE
NIPH Ann; 1983 Dec; 6(2):139-49. PubMed ID: 6427704
[TBL] [Abstract][Full Text] [Related]
5. Vaccination of dairy cows with recombinant Streptococcus uberis adhesion molecule induces antibodies that reduce adherence to and internalization of S. uberis into bovine mammary epithelial cells.
Prado ME; Almeida RA; Ozen C; Luther DA; Lewis MJ; Headrick SJ; Oliver SP
Vet Immunol Immunopathol; 2011 Jun; 141(3-4):201-8. PubMed ID: 21477869
[TBL] [Abstract][Full Text] [Related]
6. Nasal secretions of Neisseria lactamica carriers have an inhibitory effect on Neisseria meningitidis attachment to human oroepithelial cells.
Andrade JR; Marques Mda C; de Santa Rosa MR
Mem Inst Oswaldo Cruz; 1986; 81(4):453-7. PubMed ID: 3112512
[TBL] [Abstract][Full Text] [Related]
7. Cellular immunity in patients with meningococcal disease and in vaccinated subjects.
Greenwood BM; Oduloju AJ; Ade-Serrano MA
Clin Exp Immunol; 1979 Oct; 38(1):9-15. PubMed ID: 118835
[TBL] [Abstract][Full Text] [Related]
8. Antibody response to serogroup A and C meningococcal polysaccharide vaccines in infants born of mothers vaccinated during pregnancy.
McCormick JB; Gusmão HH; Nakamura S; Freire JB; Veras J; Gorman G; Feeley JC; Wingo P
J Clin Invest; 1980 May; 65(5):1141-4. PubMed ID: 6767739
[TBL] [Abstract][Full Text] [Related]
9. Meningococcal group B vaccine trial in Norway 1981--1982. Preliminary report of results available November 1982.
Frøholm LO; Berdal BP; Bøvre K; Gaustad P; Harboe A; Holten E; Høiby EA; Lystad A; Omland T; Frasch CE
NIPH Ann; 1983 Dec; 6(2):133-8. PubMed ID: 6427703
[TBL] [Abstract][Full Text] [Related]
10. [Humoral immune response to the proteins of an antimeningococcal BC vaccine in a trial carried out in Antioquia, Colombia].
Echeverry Uribe ML; Malberty Agüero JA; Galeano Marín LA; Sotolongo Padrón FT; Galguera Domínguez MA; Montoya Barrientos CM; Blanco González R; Martínez Ruiz O; Martínez Fernández OM; Aguirre Muñoz CA
Bol Oficina Sanit Panam; 1995 Apr; 118(4):285-94. PubMed ID: 7779283
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age.
Peltola H; Mäkelä H; Käyhty H; Jousimies H; Herva E; Hällström K; Sivonen A; Renkonen OV; Pettay O; Karanko V; Ahvonen P; Sarna S
N Engl J Med; 1977 Sep; 297(13):686-91. PubMed ID: 408682
[TBL] [Abstract][Full Text] [Related]
12. [The antibody response of animals to a corpuscular meningococcal group-B preparation with different methods of immunization].
Aleksakhina NN; Basnak'ian IA; Kolenko VM; Borovkova VM; Saraeva LV; Stukalova NV; Karabak VI
Zh Mikrobiol Epidemiol Immunobiol; 1992; (7-8):30-4. PubMed ID: 1466168
[TBL] [Abstract][Full Text] [Related]
13. Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man.
Zollinger WD; Mandrell RE; Griffiss JM; Altieri P; Berman S
J Clin Invest; 1979 May; 63(5):836-48. PubMed ID: 109466
[TBL] [Abstract][Full Text] [Related]
14. The effect of meningococcal group A and C polysaccharide vaccine on nasopharyngeal carrier state.
Stroffolini T; Angelini L; Galanti I; Occhionero M; Congiu ME; Mastrantonio P
Microbiologica; 1990 Jul; 13(3):225-9. PubMed ID: 2125684
[TBL] [Abstract][Full Text] [Related]
15. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
Jennings HJ
Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
[No Abstract] [Full Text] [Related]
16. Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease.
Litt DJ; Savino S; Beddek A; Comanducci M; Sandiford C; Stevens J; Levin M; Ison C; Pizza M; Rappuoli R; Kroll JS
J Infect Dis; 2004 Oct; 190(8):1488-97. PubMed ID: 15378443
[TBL] [Abstract][Full Text] [Related]
17. A potential polyvalent Neisseria meningitidis vaccine based on a mixture of CaCl2 cell extracts from groups A, B and Y.
Bisaillon JG; McSween G; Portelance V; Beaudet R; Morosoli R; Pouliot P; Micusan V
Microbios; 1989; 60(244-245):193-208. PubMed ID: 2515422
[TBL] [Abstract][Full Text] [Related]
18. Outer membrane vesicles (OMVs) and detoxified lipooligosaccharide (dLOS) obtained from Brazilian prevalent N. meningitidis serogroup B strains protect mice against homologous and heterologous meningococcal infection and septic shock.
Jessouroun E; da Silveira IF; Larangeira AP; Pereira S; Fernandes SA; Rabinovitch L; Frasch CE; Castro-Faria-Neto HC; Bozza PT
Vaccine; 2004 Jun; 22(20):2617-25. PubMed ID: 15193387
[TBL] [Abstract][Full Text] [Related]
19. Serum antibodies to capsular polysaccharide vaccine of group A and C Neisseria meningitidis in military recruits in Italy.
Occhionero M; Usai G; Di Martino M; Le Moli S; Stroffolini T; Mastrantonio P
Allergol Immunopathol (Madr); 1991; 19(1):39-41. PubMed ID: 1950941
[TBL] [Abstract][Full Text] [Related]
20. Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.
Rosenqvist E; Høiby EA; Bjune G; Aase A; Halstensen A; Lehmann AK; Paulssen J; Holst J; Michaelsen TE; Nøkleby H; Frøholm LO; Closs O
Dev Biol Stand; 1998; 92():323-33. PubMed ID: 9554288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
